Author

D. R. Raju

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Scientific Communication & Education· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:clinical cohort / trial· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Chandele· 1 shared A. Patel· 1 shared A. S. Neish· 1 shared A. Sharma· 1 shared C. Chakravarthy· 1 shared C. W. Davis· 1 shared E. A. Ortlund· 1 shared E. S. Reddy· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Chandele

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody response

A. Patel, S. Kumar, L. Lai, C. Chakravarthy, R. Valanparambil, E. S. Reddy, K. Gottimukkala, P. Bajpai, D. R. Raju, V. V. Edara, M. E. Davis-Gardner, S. Linderman, K. Dixit, P. Sharma, G. Mantus, , E. A. Ortlund

The paper identifies three monoclonal antibodies that poorly neutralize the Omicron BA.1 variant, revealing structural and molecular features of antibody evasion.

bioRxiv · Oct 24, 2022Immunology

Analysis of Costs and Strategies for Using Academic Research in a Private Dental College to Develop Commercially Viable Products

R. V. Chandra, D. R. Raju

The paper analyzes research projects in a private dental college to identify commercially viable products and assess variables affecting their commercialization potential.

bioRxiv · Jun 2, 2020 · PreprintScientific Communication & Education